HD-tDCS as a Treatment for Chronic Tinnitus

September 24, 2020 updated by: University Hospital, Antwerp

High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Chronic Tinnitus: Outcomes From a Prospective Longitudinal Large Cohort Study

Transcranial Direct Current Stimulation (tDCS) aims to induce cortical plasticity by modulating the activity of brain structures. The broad stimulation pattern, which is one of the main limitations of tDCS, can be overcome with the recently developed technique called High-Definition tDCS (HD-TDCS). The objective of the current study is to investigate the effect of HD-tDCS on tinnitus in a large patient cohort.

Study Overview

Study Type

Interventional

Enrollment (Actual)

117

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • chronic, subjective, non-pulsatile tinnitus
  • met the criteria for HD-tDCS safety

Exclusion Criteria:

  • a middle ear pathology
  • another tinnitus treatment ongoing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: HD-tDCS
Each patient received a total of six sessions of anodal HD-tDCS of right DLPFC.
1x1 tDCS low-intensity stimulator and 4x1 multichannel stimulation adaptor (Soterix Medical Inc, New York, NY)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Tinnitus Functional Index (TFI)
Time Frame: Baseline (before intervention), immediately post intervention, 7 weeks follow-up
Tinnitus severity self-report questionnaire, ranging from 0-100 with a higher score representing a more severe tinnitus
Baseline (before intervention), immediately post intervention, 7 weeks follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Visual Analogue scale (VAS) for tinnitus loudness
Time Frame: Baseline (before intervention), immediately post intervention, 7 weeks follow-up
Visual analogue scale measuring tinnitus loudness from 0-100, with a higher score representing a louder tinnitus Visual analogue scale measuring tinnitus loudness from 0-100, with a higher score representing a louder tinnitus
Baseline (before intervention), immediately post intervention, 7 weeks follow-up
Change in Hospital Anxiety and Depression Scale (HADS)
Time Frame: Baseline (before intervention), immediately post intervention, 7 weeks follow-up
Self-report questionnaire concerning anxiety and depression symptoms, ranging from 0-21 for each subscale. A result greater than 8 suggests the presence of a depression and/or anxiety disorder. Visual analogue scale measuring tinnitus loudness from 0-100, with a higher score representing a louder tinnitus
Baseline (before intervention), immediately post intervention, 7 weeks follow-up
Change in Tinnitus Questionnaire (TQ)
Time Frame: Baseline (before intervention), immediately post intervention, 7 weeks follow-up
Tinnitus severity self-report questionnaire, ranging from 0-84 with a higher score representing a more distressing tinnitus
Baseline (before intervention), immediately post intervention, 7 weeks follow-up
Change in Hyperacusis Questionnaire (HQ)
Time Frame: Baseline (before intervention), immediately post intervention, 7 weeks follow-up
Hyperacusis severity self-report questionnaire, ranging from 0-42 with a higher score representing a higher sensitivity to sounds. A score of 28 is the cut-off for auditory hypersensitivity.
Baseline (before intervention), immediately post intervention, 7 weeks follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 21, 2016

Primary Completion (Actual)

April 8, 2019

Study Completion (Actual)

April 9, 2019

Study Registration Dates

First Submitted

August 12, 2020

First Submitted That Met QC Criteria

September 24, 2020

First Posted (Actual)

September 25, 2020

Study Record Updates

Last Update Posted (Actual)

September 25, 2020

Last Update Submitted That Met QC Criteria

September 24, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tinnitus, Subjective

Clinical Trials on High Definition transcranial Direct Current Stimulation

Subscribe